Atlas Trials

Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection

Clinical trial NCT05126121 · UNKNOWN

Trial details

NCT number
NCT05126121
Sponsor
Xiuli Zuo
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2021-11-20
Primary completion
2022-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.